Clinical Trial Update: A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease [Phase 2]

View source ↗

Summary

This document provides an update on the Phase 2 trial of Mevidalen (LY3154207) for Alzheimer's disease, noting the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Mevidalen (LY3154207)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Alzheimer Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING